Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.44 |
| ▸ | PTGIR | P43119 | 11/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | PTGDR | Q13258 | 2/20 | 0.33 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8809500 | 0.81 | PTGIR (0.47) | TBXAS1PTGIRKDM4C | |
| SCHEMBL8811309 | 0.81 | PTGIR (0.47) | TBXAS1PTGIRKDM4C | |
| SCHEMBL8413479 | 0.77 | TBXAS1 (0.37) | TBXAS1PTGIRPPARDPLA2G1BLMNA | |
| SCHEMBL8410752 | 0.74 | TBXAS1 (0.48) | TBXAS1PTGIRPTGDR | |
| SCHEMBL8811213 | 0.74 | PTGDR2 (0.38) | TBXAS1PTGIR | |
| SCHEMBL8808600 | 0.74 | PTGDR2 (0.38) | TBXAS1PTGIR | |
| SCHEMBL8414476 | 0.74 | PTGDR2 (0.38) | TBXAS1PTGIR | |
| SCHEMBL8520586 | 0.74 | PTGIR (0.45) | TBXAS1PTGIRKDM4C | |
| SCHEMBL8412819 | 0.73 | PTGIR (0.47) | TBXAS1PTGIRPPARDPLA2G1BLMNA | |
| SCHEMBL8520476 | 0.72 | PTGIR (0.64) | TBXAS1PTGIRPLA2G1BKDM4CPTGDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5962439-A | CARDIOVASCULAR DISORDER | ONO PHARMACEUTICAL CO., LTD. (JP) | 1999-10-05 | — | — | US | claimed |
| EP-0548949-B1 | Fused benzeneoxyacetic acid derivatives | ONO PHARMACEUTICAL CO (JP) | 1997-09-17 | — | — | EP | claimed |
| EP-0548949-A2 | Fused benzeneoxyacetic acid derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1993-06-30 | — | — | EP | claimed |
| US-5962439-A | CARDIOVASCULAR DISORDER | ONO PHARMACEUTICAL CO., LTD. (JP) | 1999-10-05 | — | — | US | disclosed |
| US-5849919-A | Fused benzeneoxyacetic acid derivatives which have PGI2 receptor anonist activity | ONO PHARMACEUTICAL CO., LTD. (JP) | 1998-12-15 | — | — | US | disclosed |
| EP-0548949-B1 | Fused benzeneoxyacetic acid derivatives | ONO PHARMACEUTICAL CO (JP) | 1997-09-17 | — | — | EP | disclosed |
| US-5589496-A | Fused benzeneoxyacetic acid derivatives which have PGI2 receptor agonist activity | ONO PHARMACEUTICAL CO., LTD. (JP) | 1996-12-31 | — | — | US | disclosed |
| US-5389666-A | Administering for treatment and prevention of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension | ONO PHARMACEUTICAL CO., LTD. (JP) | 1995-02-14 | — | — | US | disclosed |
| EP-0548949-A2 | Fused benzeneoxyacetic acid derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1993-06-30 | — | — | EP | disclosed |